Escalon Medical Corp financial data

Symbol
ESMC on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
435 Devon Park Road, Suite 824, Wayne, PA
State of incorporation
PA
Fiscal year end
June 30
Latest financial report
10-Q - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 170 % +4.53%
Quick Ratio 68.1 % +18.8%
Debt-to-equity 155 % -9.12%
Return On Equity 10.2 % -72.4%
Return On Assets 4.01 % -70.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.42M shares 0%
Common Stock, Shares, Outstanding 7.42M shares 0%
Entity Public Float 773K USD +333%
Common Stock, Value, Issued 7.42K USD 0%
Weighted Average Number of Shares Outstanding, Basic 7.42M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +89.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.7M USD -21.5%
Revenue from Contract with Customer, Excluding Assessed Tax 3.22M USD +12.2%
Research and Development Expense 626K USD -13.4%
Costs and Expenses 12M USD +2.42%
Operating Income (Loss) 211K USD -70.3%
Nonoperating Income (Expense) -5.26K USD +5.19%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 186K USD -72.9%
Earnings Per Share, Basic 0 USD/shares -100%
Earnings Per Share, Diluted 0 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 209K USD -76.5%
Accounts Receivable, after Allowance for Credit Loss, Current 2.12M USD +28.4%
Inventory, Net 1.72M USD +22.1%
Other Assets, Current 197K USD -6.73%
Assets, Current 4.3M USD +3.22%
Property, Plant and Equipment, Net 38.2K USD -37.3%
Operating Lease, Right-of-Use Asset 42.3K USD -88%
Assets 4.49M USD -4.67%
Accounts Payable, Current 892K USD -9.69%
Employee-related Liabilities, Current 472K USD +0.32%
Accrued Liabilities, Current 705K USD +7.16%
Liabilities, Current 2.21M USD -13.1%
Operating Lease, Liability, Noncurrent 7.37K USD -81.2%
Liabilities 2.46M USD -14.1%
Retained Earnings (Accumulated Deficit) -68.3M USD +0.27%
Stockholders' Equity Attributable to Parent 2.02M USD +10.1%
Liabilities and Equity 4.49M USD -4.67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 33.3K USD
Net Cash Provided by (Used in) Financing Activities -12.6K USD -20.1%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 35M shares 0%
Common Stock, Shares, Issued 7.42M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 20.7K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 777K USD +20.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.55K USD +17.3%
Deferred Tax Assets, Valuation Allowance 7.61M USD +0.71%
Deferred Tax Assets, Gross 7.67M USD -0.98%
Operating Lease, Liability 216K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 45.3K USD -88.6%
Property, Plant and Equipment, Gross 995K USD +5.24%
Operating Lease, Liability, Current 35.7K USD -89.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.01K USD -97.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 33.8K USD -80.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +17.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.91K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.28K USD -42%
Deferred Tax Assets, Operating Loss Carryforwards 7.14M USD +1.55%
Preferred Stock, Shares Issued 2M shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.28K USD +89.8%
Additional Paid in Capital 69.7M USD 0%
Preferred Stock, Shares Outstanding 200K shares
Depreciation, Depletion and Amortization 10.6K USD -3.65%
Deferred Tax Assets, Net of Valuation Allowance 59.6K USD -68.4%
Interest Expense 20.8K USD -4.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%